Antigua and Barbuda vs Denmark: Protecting minority investors: Ease of shareholder suits index (0-10)
Antigua and Barbuda
70
in 2013
Denmark
70
in 2013
Antigua and Barbuda rank
44th
Denmark rank
44th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Antigua and Barbuda
- Denmark
How they compare
Antigua and Barbuda currently reports 70 against 70 in Denmark, a difference of 0.
Across all 9 years both countries report, Denmark has been ahead every year.
Antigua and Barbuda ranks 44th and Denmark ranks 44th of 191 countries.
Head to head by decade
| Decade | Antigua and Barbuda | Denmark | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70 | 70 | 0 | — |
| 2010s | 70 | 70 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Antigua and Barbuda or Denmark?
- Antigua and Barbuda, at 70 against 70 in Denmark as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Antigua and Barbuda and Denmark?
- 0, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Denmark?
- 9 years are reported by both, from 2005 to 2013.
- How do Antigua and Barbuda and Denmark rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Antigua and Barbuda ranks 44th and Denmark ranks 44th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.